Skip to main content

Table 3 Information about given NAC and hemoglobin values in the 87 patients who received NAC

From: A retrospective evaluation of preoperative anemia in patients undergoing radical cystectomy for muscle-invasive urothelial urinary bladder cancer, with or without neoadjuvant chemotherapy

Variable Total (n = 87)
NAC treatment  
 MVAC 53 (60.9)
 HD-MVAC 21 (24.1)
 Cisplatin-Gemzar 6 (6.9)
 MVEC 5 (5.7)
 Carboplatin-Gemzar 1 (1.1)
 MVAC + Taxotere 1 (1.1)
Hemoglobin level (g/L)  
 Prior to NAC 127 (117–127)
 Prior to surgery 115 (107–123)
 Anemic prior to NAC 48 (55.2)
 Anemic prior to surgery 70 (80.5)
 Number of days from last NAC to surgery 35 (29–42)
  1. Data are shown as median (IQR) or n (%)